We have determined that besides its well-defined function in the p38-inflammatory pathway, MKK3 can induce MYC-dependent epithelial-to-mesenchymal transition in breast cancer patients in part through upregulation of EIF5A, EIF5AL1, and SNAI1 genes. This evidence concerns the gene MAPK14 and breast cancer.